FDA Inspection
Daewoo Pharmaceutical Co., Ltd.Daewoo Pharmaceutical Co., Ltd. – FDA Inspection, Mar 28, 2017
Record Details
This FDA Inspection record concerns Daewoo Pharmaceutical Co., Ltd., with an inspection on March 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b12c557e-cbb4-4a90-b581-84babb6d154a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1009230
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.113(b)Procedures for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Daewoo Pharmaceutical Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 15, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Daewoo Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.